Arcturus Therapeutics Ltd. Revenue
Arcturus Therapeutics Ltd. reported Revenue of $15.75 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-03-18
- Arcturus Therapeutics Ltd. revenues for the quarter ending 2018-12-31 was $7.58M, a 275.10% increase year-over-year.
- Arcturus Therapeutics Ltd. revenues for the quarter ending 2018-09-30 was $3.42M, a 3.85% increase year-over-year.
- Arcturus Therapeutics Ltd. revenues for the quarter ending 2018-06-30 was $2.39M, a 36.56% decline year-over-year.
- Arcturus Therapeutics Ltd. revenues for the quarter ending 2018-03-31 was $2.37M, a 39.63% decline year-over-year.
- Arcturus Therapeutics Ltd. revenues for fiscal 2018 was $15.75M, a 21.20% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. revenues for fiscal 2017 was $13.00M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $7.58M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $11.00M derived: sum of 2 quarters · filed 2019-03-18 | $13.39M derived: sum of 3 quarters · filed 2019-03-18 | $15.75M 10-K · filed 2019-03-18 |
| 2018-09-30 | $3.42M 6-K · filed 2018-11-07 | $5.81M derived: sum of 2 quarters · filed 2018-11-07 | $8.18M 6-K · filed 2018-11-07 | $10.20M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | $2.39M 6-K · filed 2018-11-07 | $4.75M 6-K · filed 2018-09-28 | $6.77M derived: sum of 3 quarters · filed 2018-11-07 | $10.07M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-03-31 | $2.37M 6-K · filed 2018-11-07 | $4.39M derived: sum of 2 quarters · filed 2018-11-07 | $7.68M derived: sum of 3 quarters · filed 2018-11-07 | $11.44M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-12-31 | $2.02M 6-K · filed 2018-11-07 | $5.32M derived: sum of 2 quarters · filed 2018-11-07 | $9.08M derived: sum of 3 quarters · filed 2018-11-07 | $13.00M 10-K · filed 2019-03-18 |
| 2017-09-30 | $3.30M 6-K · filed 2018-11-07 | $7.06M derived: sum of 2 quarters · filed 2018-11-07 | $10.98M 6-K · filed 2018-11-07 | |
| 2017-06-30 | $3.76M 6-K · filed 2018-11-07 | $7.68M 6-K · filed 2018-09-28 | ||
| 2017-03-31 | $3.92M 6-K · filed 2018-11-07 | |||
| 2016-12-31 | $20.38M 20-F · filed 2018-05-14 | |||
| 2015-12-31 | $6.14M 20-F · filed 2018-05-14 |